Combination of a PD-1 antagonist and an ALK inhibitor for treating cancer Grant US-10695426-B2 United States of America 30 Jun 2020
Xanthohumol and tetrahydro-isoalpha acid based protein kinase modulation cancer treatment Grant US-7736677-B2 United States of America 15 Jun 2010